Oxytrol patch (Oxybutynin)

Oxytrol patch is called Kentera in Europe.

Information about Oxytrol patch (Oxybutynin)

Oxytrol Patch is a transdermal patch formulation containing oxybutynin, an anticholinergic medication used to treat overactive bladder (OAB) symptoms. The patch provides continuous delivery of oxybutynin through the skin, helping to reduce urinary frequency, urgency, and incontinence. By delivering the medication directly through the skin, the Oxytrol patch offers an alternative to oral oxybutynin, with potentially fewer systemic side effects.

Product Highlights

• The Oxytrol patch is primarily indicated for:
• It helps manage symptoms of OAB, including urinary urgency, frequency, and urge incontinence. 
• This condition involves frequent, sudden urges to urinate, which may lead to accidental leakage.

Key Ingredient

• Oxybutynin

Key Benefits

• Oxybutynin helps reduce symptoms of overactive bladder, such as frequent urination, urinary urgency, and incontinence.
• The Oxytrol patch is easy to apply and provides continuous medication release for 3-4 days, reducing the need for daily oral doses.
• Since the patch delivers oxybutynin directly through the skin, it may result in fewer systemic side effects compared to oral oxybutynin, particularly on the gastrointestinal system.
• The patch form is a convenient alternative for patients who have difficulty adhering to oral medications or those who experience gastrointestinal side effects from oral formulations.
• As the medication is delivered directly through the skin, the risk of liver and kidney strain may be lower compared to oral oxybutynin, which is metabolized by these organs.

Direction of Use

• The usual recommended dose of Oxytrol patch is one patch applied to the skin every 3 to 4 days.
• Apply the patch to a clean, dry area of the skin, such as the lower abdomen, hips, or buttocks.
• Do not apply the patch to areas with cuts, irritation, or too much hair.
• Once applied, the patch will gradually release oxybutynin into the bloodstream over time.
• For best results, change the patch every 3-4 days, rotating the application site to avoid skin irritation.
• Continue using the patch as directed by your healthcare provider. If a patch becomes loose or falls off, replace it with a new patch on a new site.

Safety Concerns

• Some side effects associated with oxybutynin include dry mouth, constipation, blurred vision, dizziness, and skin irritation at the site of application. These side effects are usually mild and tend to improve with time.
• Oxybutynin is an anticholinergic drug, and like other medications in this class, it can cause confusion, memory problems, or difficulty concentrating, particularly in elderly patients.
• The Oxytrol patch may not adhere well to the skin if exposed to excessive heat (e.g., from hot tubs, saunas, or exercise). Heat can also increase the absorption of the medication, leading to higher-than-intended doses.
• Caution is needed in patients with a history of cardiovascular issues such as arrhythmias, as oxybutynin can cause tachycardia (increased heart rate).
• Patients with narrow-angle glaucoma should use caution, as oxybutynin can exacerbate this condition by increasing intraocular pressure.

Avoid Oxytrol Patch (Oxybutynin) If

• Do not use Oxytrol if you are allergic to oxybutynin or any of the other ingredients in the patch.
• Oxybutynin can increase intraocular pressure, making it unsuitable for individuals with narrow-angle glaucoma.
• If you have severe difficulty urinating, you should avoid Oxytrol, as it may worsen urinary retention.
• Individuals with gastrointestinal issues such as obstructive bowel disease, ileus, or severe constipation should avoid the patch.
• Oxybutynin can exacerbate the symptoms of myasthenia gravis, a condition characterized by muscle weakness, and should be avoided in patients with this condition.
• The safety of Oxytrol during pregnancy and breastfeeding has not been established. It should be used during pregnancy only if the potential benefits outweigh the risks to the fetus, and with caution in breastfeeding mothers, as the drug may pass into breast milk.